Clinical Trial

Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
* Assess response to treatment in children with bronchial asthma attending Assiut university children hospital. * Role of comorbidities in controlling symptoms of bronchial asthma. * Evaluate the role of the soluable interleukin 5 receptor, I C-telopeptide of type I collagen (ICTP), miR-223-3p and miR-191-5p in bronchial asthma.
Trial Details
NCT Number NCT07230912
Lead Sponsor Assiut University
Conditions Bronchial Asthma
Enrollment 82 participants
Start Date 2025-12-30
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-11-17